(Q73196592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

left ventricular hypertrophy

2 November 2019

main subject

1 reference

F Manelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Desenzani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Boni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Bugari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Negrini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Romanelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

V Grassi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Giustina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

205-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11081155%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1009997011064

2 November 2019

exact match

0 references

cites work

Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion

1 reference

12 December 2020

1 reference

12 December 2020

The anaerobic threshold: definition, physiological significance and identification

1 reference

12 December 2020

The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study

1 reference

12 December 2020

Octreotide treatment increases exercise capacity in patients with acromegaly

1 reference

12 December 2020

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

1 reference

12 December 2020

Cardiac size and function in acromegaly

1 reference

12 December 2020

The pharmacological aspects of the treatment of acromegaly

1 reference

12 December 2020

Cardiac function in acromegaly.

1 reference

12 December 2020

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide

1 reference

12 December 2020

Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study

1 reference

12 December 2020

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

1 reference

12 December 2020

Acromegalic heart disease: influence of treatment of the acromegaly on the heart.

1 reference

12 December 2020

Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide

1 reference

12 December 2020

Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly

1 reference

12 December 2020

Continuous subcutaneous pump infusion of somatostatin analogue SMS 201-995 versus subcutaneous injection schedule in acromegalic patients

1 reference

12 December 2020

Impaired spontaneous growth hormone secretion in severe dialated cardiomyopathy

1 reference

12 December 2020

Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034

1 reference

12 December 2020

Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation

1 reference

12 December 2020

Impaired left ventricular diastolic function in acromegaly: an echocardiographic study.

1 reference

12 December 2020

Acromegalic cardiopathy improves after treatment with increasing doses of octreotide

1 reference

12 December 2020

Growth Hormone Improves Cardiac Performance in Experimental Heart Failure

1 reference

12 December 2020

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

1 reference

12 December 2020

Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insights.

1 reference

12 December 2020

Effect of ramp slope on determination of aerobic parameters from the ramp exercise test

1 reference

12 December 2020

Haemodynamic effects of intravenous growth hormone in congestive heart failure

1 reference

12 December 2020

Acromegaly and cardiovascular disorders. A prospective study

1 reference

12 December 2020

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers

1 reference

12 December 2020